|
COVID-19 vaccine commercialization is underway and changes are happening fast! This means very soon COVID-19 vaccines will be available to enrolled providers in the Childhood Vaccine Program and provided for all children under the age of 19 at no cost to patients.
We anticipate that COVID-19 vaccine will be available in the IIS to order tomorrow September 15th. We will communicate more information as it becomes available and when the order sets are in the IIS and open for providers.
Once the COVID-19 vaccine is available to order through the Childhood Vaccine Program, you may notice some differences from the pandemic COVID-19 Vaccine Program:
-
Only order what you can use and consider your storage capacity, order quantities can be small with a minimum order size of ten.
-
Orders can be placed anytime throughout the month, similar to flu vaccine orders for children.
-
All CVP accountability requirements apply to COVID-19 vaccines so ensure your temperature logs and inventory reports are up to date prior to placing your COVID-19 vaccine order.
-
Depots of COVID-19 vaccine are no longer allowed. Every provider should place their own COVID-19 vaccine order for shipment directly to their clinic for only the number of doses your clinic can use.
-
Keep waste to a minimum, order appropriately and submit your vaccine returns when appropriate. Do not discard vaccine.
-
Ancillary kits will no longer be provided. Please ensure you have adequate supply of syringes, needles, and other ancillary supplies to administer COVID-19 vaccines.
-
COVID-19 vaccines will no longer ship within 48 hours but will now align with routine vaccine shipping timeframes.
Stay tuned to this newsletter as more important details develop!
There will be six different COVID-19 products available to order through the Childhood Vaccine Program:
 Please note that some presentations require ultra-cold storage capability, and some have specific age indications. Please order only what your clinic is able to store and administer according to these requirements. If you have an additional storage unit to add to your CVP provider agreement to store COVID-19 vaccines, please request your agreement be returned to you for edits.
More detailed product guides coming soon!
As part of FDA’s actions, the bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States. To minimize the risk of vaccine administration errors, providers should:
- Remove all bivalent mRNA COVID-19 vaccines from storage units immediately, even if they are not expired.
- Dispose of all bivalent mRNA COVID-19 vaccine vials in accordance with local, state, and federal regulations.
- Report all disposed inventory as wastage.
Remove Bivalent mRNA COVID-19 Vaccines from Your Inventory
The table below provides a listing of COVID-19 bivalent vaccines that should be removed from your inventory. For additional information, see IIS COVID-19 Vaccine Related Code | CDC.
Please make sure you join the very timely and important training session on Thursday, September 21st. The topic will include all the information you need to know for COVID-19 vaccine storage and handling requirements. Please make time to join this training session and bring all your questions!
Date: September 21, 2023
Time: 12:00 pm (noon)
Topic: Storage and Handling Requirements for COVID-19 Vaccine
Intended Audience: CVP and AVP Providers and Vaccine Coordinators
As always, this training session will be recorded and posted to our training webpage.
Any COVID-19 vaccine obtained after commercialization, shall use the code/funding structure below:
- Bridge Vaccine – Dose Eligibility V23 and Funding Source VXC50
- Pharmacy Program – Dose Eligibility V01 and Funding Source VXC50 or VXC52
- Patient eligibility and funding codes shall align with the state eligibility guide for all other COVID-19 vaccines.
- Public Supplied VFC vaccine (state supplied VFC vaccine) – Dose Eligibility V02, V03, V04, and V05; Funding Source VXC51.
- Public Supplied Non-VFC vaccine (state supplied vaccines provided to CHIP and/or privately insured children) – Dose Eligibility V22 or V25; Funding Source VXC52.
- Public Supplied AVP vaccine – Dose Eligibility V23; Funding Source VXC52.
- Private Purchase vaccine (vaccine purchased outside of these programs) – Dose Eligibility V01 and V24; Funding Source PHC70.
We recommend vaccine clinic staff reach out to their EHR and IT support teams to be sure any system updates needed to support these changes are identified.
|
